GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DHG Pharmaceutical JSC (STC:DHG) » Definitions » Beneish M-Score

DHG Pharmaceutical JSC (STC:DHG) Beneish M-Score : -2.68 (As of Dec. 14, 2024)


View and export this data going back to 2006. Start your Free Trial

What is DHG Pharmaceutical JSC Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.68 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for DHG Pharmaceutical JSC's Beneish M-Score or its related term are showing as below:

STC:DHG' s Beneish M-Score Range Over the Past 10 Years
Min: -3.01   Med: -2.39   Max: -1.3
Current: -2.68

During the past 13 years, the highest Beneish M-Score of DHG Pharmaceutical JSC was -1.30. The lowest was -3.01. And the median was -2.39.


DHG Pharmaceutical JSC Beneish M-Score Historical Data

The historical data trend for DHG Pharmaceutical JSC's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DHG Pharmaceutical JSC Beneish M-Score Chart

DHG Pharmaceutical JSC Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.84 -2.85 -2.14 -2.45 -1.30

DHG Pharmaceutical JSC Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.62 -1.30 -2.15 -2.47 -2.68

Competitive Comparison of DHG Pharmaceutical JSC's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DHG Pharmaceutical JSC's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where DHG Pharmaceutical JSC's Beneish M-Score falls into.



DHG Pharmaceutical JSC Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of DHG Pharmaceutical JSC for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9196+0.528 * 1.1219+0.404 * 1.0243+0.892 * 1.0312+0.115 * 0.8445
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9428+4.679 * -0.027418-0.327 * 1.2787
=-2.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was ₫541,373 Mil.
Revenue was 1061838.685 + 1105832.177 + 1258518.524 + 1534725.363 = ₫4,960,915 Mil.
Gross Profit was 461251.784 + 497621.013 + 512497.202 + 653095.669 = ₫2,124,466 Mil.
Total Current Assets was ₫4,833,774 Mil.
Total Assets was ₫6,253,273 Mil.
Property, Plant and Equipment(Net PPE) was ₫1,126,862 Mil.
Depreciation, Depletion and Amortization(DDA) was ₫107,905 Mil.
Selling, General, & Admin. Expense(SGA) was ₫574,898 Mil.
Total Current Liabilities was ₫1,774,141 Mil.
Long-Term Debt & Capital Lease Obligation was ₫0 Mil.
Net Income was 156014.719 + 192484.446 + 222228.744 + 260288.226 = ₫831,016 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₫0 Mil.
Cash Flow from Operations was 238946.738 + 237438.436 + 365565.63 + 160520.264 = ₫1,002,471 Mil.
Total Receivables was ₫570,889 Mil.
Revenue was 1099461.735 + 1152649.915 + 1228558.027 + 1330288.482 = ₫4,810,958 Mil.
Gross Profit was 514651.633 + 561652.368 + 614145.373 + 620884.27 = ₫2,311,334 Mil.
Total Current Assets was ₫4,647,712 Mil.
Total Assets was ₫5,989,489 Mil.
Property, Plant and Equipment(Net PPE) was ₫1,068,117 Mil.
Depreciation, Depletion and Amortization(DDA) was ₫85,104 Mil.
Selling, General, & Admin. Expense(SGA) was ₫591,328 Mil.
Total Current Liabilities was ₫1,328,931 Mil.
Long-Term Debt & Capital Lease Obligation was ₫0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(541373.383 / 4960914.749) / (570889.043 / 4810958.159)
=0.109128 / 0.118664
=0.9196

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2311333.644 / 4810958.159) / (2124465.668 / 4960914.749)
=0.480431 / 0.428241
=1.1219

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4833773.511 + 1126861.533) / 6253272.867) / (1 - (4647711.803 + 1068117.114) / 5989488.997)
=0.046798 / 0.04569
=1.0243

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4960914.749 / 4810958.159
=1.0312

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(85104.466 / (85104.466 + 1068117.114)) / (107904.547 / (107904.547 + 1126861.533))
=0.073797 / 0.087389
=0.8445

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(574898.365 / 4960914.749) / (591328.461 / 4810958.159)
=0.115886 / 0.122913
=0.9428

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 1774141.353) / 6253272.867) / ((0 + 1328931) / 5989488.997)
=0.283714 / 0.221877
=1.2787

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(831016.135 - 0 - 1002471.068) / 6253272.867
=-0.027418

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

DHG Pharmaceutical JSC has a M-score of -2.68 suggests that the company is unlikely to be a manipulator.


DHG Pharmaceutical JSC Beneish M-Score Related Terms

Thank you for viewing the detailed overview of DHG Pharmaceutical JSC's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


DHG Pharmaceutical JSC Business Description

Traded in Other Exchanges
N/A
Address
288 Bis Nguyen Van Cu, An Hoa Ward, Ninh Kieu District, Can Tho, VNM
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotic, antifungal, and antiparasitic; analgesic and antipyretic; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.

DHG Pharmaceutical JSC Headlines